Slide 1: Regulation 30 intimation to stock exchanges
November 6, 2023 To, To, BSE Limited, Listing Department, 25, P. J. Towers, National Stock Exchange of India Ltd., Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai‐ 400051 Ref: Company Scrip Code: 532834 Ref: Symbol: CAMLINFINE || Series: EQ Sub: Intimation
Slide 2: Investor Presentation – Nov 2023
Investor Presentation – Nov 2023
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Camlin Fine Sciences Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any
Slide 4: Q2 & H1 FY24 Performance Highlights
Q2 & H1 FY24 Performance Highlights 3
Slide 5: Q2 & H1FY24 Operational Highlights
Q2 & H1FY24 Operational Highlights Revenue (Rs. In Mn) EBITDA* (Rs. In Mn) PAT (Rs. In Mn) 11.4% 10.7% 7.8% 2.0% 2.9% -5.1% Margin 4,832 4,196 4,059 552 120 99 447 317 Q2FY23 Q1FY24 Q2FY24 Q2FY23 Q1FY24 Q2FY24 -208 Q2FY23 Q1FY24 Q2FY24 12.1% 9.3% 1.6% -1.1% Margin 8,670 8,255 1,047 135 764 H1FY23 H1
Slide 6: Q2 & H1FY24 Operational Highlights – Key Highlights
Q2 & H1FY24 Operational Highlights Key Highlights › Despite difficult business environment, Company was able to achieve stable turnover of INR 4,059 Mn in the current quarter as compared to INR 4,196 MnQ1 FY 24 & INR 4,832 Mn in Q2 FY 23. › Blends business has gained traction and now it has increase
Slide 7: Operational Revenue Break-up
Operational Revenue Break-up Shelf-Life Extension (Rs. In Mn) Blends (Rs. In Mn) Total Shelf-Life Solution (Rs. In Mn) 2,363 3,565 5,586 2,022 4,902 2,540 1,450 1,957 2,746 3,000 1,043 1,296 Q2FY23 Q2FY24 H1FY23 H1FY24 Q2FY23 Q2FY24 H1FY23 H1FY24 Q2FY23 Q2FY24 H1FY23 H1FY24 Performance Chemicals (Rs
Slide 8: Regional Highlights
Regional Highlights CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) 3,949 2,360 2,875 3,599 1,797 2,400 1,994 1,192 1,552 1,546 899 422 Q2FY23 Q2FY24 H1FY23 H1FY24 Q2FY23 Q2FY24 H1FY23 H1FY24 Q2FY23 Q2FY24 H1FY23 H1FY24 CFS Brazil (Rs. In Mn) CFS North America (Rs. In Mn) 801 1,2
Slide 9: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Particulars (Rs. In Mn) Q2 FY24 Q2 FY23 YoY Q1 FY24 QoQ H1 FY24 H1 FY23 Revenue from Operation 4,058.8 4,832.5 -16.0% 4,196.0 -3.3% 8,254.8 8,670.2 Raw material consumption 2,236.1 2,384.6 2,157.8 4,393.9 4,166.0 Employee Cost 432.4 389.6 438.5 870.9 800.8 Other
Slide 10: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement Particulars (Rs. In Mn) Q2 FY24 Q2 FY23 YoY Q1 FY24 QoQ H1 FY24 H1 FY23 Revenue from Operation 2,062.1 2,431.5 -15.2% 1,611.1 28.0% 3,673.3 3,985.9 Raw material consumption 1,078.2 1,185.1 632.2 1,710.4 1,968.1 Employee Cost 177.0 129.5 154.8 331.8 269.6 Other expe
Slide 11: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (Rs. In Mn) Sep – 23 Mar - 23 Particulars (Rs. In Mn) Sep - 23 Mar - 23 Equity Non-Current assets Equity Share Capital 167.5 157.1 Property, Plant and Equipment 7,338.6 7,525.2 Other Equity 9,262.8 8,036.6 Capital Work-In-Progress 497.0 408.4 Minority interest
Slide 12: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars (Rs. In mn) Sep – 23 Sep - 22 Net Profit Before Tax 39.9 401.6 Adjustments for: Non-Cash Items / Other Investment or Financial Items 742.9 607.8 Operating profit before working capital changes 782.8 1,009.4 Changes in working capital -128.2 -739.2 Cash ge
Slide 13: Touching Billions of Lives Daily
Touching Billions of Lives Daily Vertical Integration | Green Chemistry | R&D | Innovative Solutions
Slide 14: Company Overview
Company Overview 1,250+ Base of Satisfied Customers Worldwide 100 + Range of Diversified Products 61,000 + MT Led by Integrated Global Among Global Leaders Production Capacity Catering Diverse Industries In the Manufacturing of Antioxidants Food and Beverage Animal Nutrition Pet Food Preferred Partn
Slide 15: Global Footprint
Global Footprint Capacity (in MT) 9 5 31,000 12,000 Global Manufacturing Application CFS Europe SpA, Italy Camlin Fine Sciences, India Facilities Laboratories 80+ 2 6,000 CFS do Brasil 12,000 CFS Dresen, Mexico Countries Global R&D Centres Sales Network CFA Europe SpA, Italy, CFS has multiple operat
Slide 16: Product Highlights
Product Highlights FY23 Sales Mix% Key Products End User Industries Key Brands › TBHQ › Pet Food › Animal Feed Mills Straights 28% › BHA › Livestock Nutrition › Biodiesel › Ascorbyl palmitate (ASP) › Food & Beverages › Aquaculture › Fish Meal › Rendering Shelf-Life Solutions › 200+ custom formulatio
Slide 17: Vertical Integration | Green Chemistry | R&D | Innovative Solutions
Vertical Integration | Green Chemistry | R&D | Innovative Solutions From Source, to Quality Solutions • Efforts in both organic and inorganic expansions, showcases company’s commitment to fortifying position in the market Backward Integrated through Italy & Dahej • Strategic focus on captive consumpt
Slide 18: Manufactured In-house Integration Chain
Integration Chain Phenol Hydroquinone Diphenols Catechol Manufactured In-house Performance Performance Shelf Life Solutions Chemicals Aroma Ingredients Chemicals Ascorbyl Palmitate1 TBHQ MEHQ Guaiacol Guethol BHA Other derivatives of HQ Veratrole Vanillin Other derivatives of Blends Ethyl Vanillin C
Slide 19: ESG
ESG As a responsible corporate, CFS understand the importance of Environmental, Social and Governance (ESG) practices in conducting business ethically. Company’s commitment to ESG extends beyond compliance with regulations and laws. Company aims to minimize environmental impact, promote social respo
Slide 20: Board of Directors
Board of Directors Name Profile Ashish Dandekar › Over three decades of experience in pharmaceuticals and specialty chemical products including business planning, information systems, research Chairman & Managing Director & development, product development, and marketing › Holds a BA in Economics an
Slide 21: Senior Management Team
Senior Management Team Name › Profile Ashish Dandekar › Over three decades of experience in pharmaceuticals and specialty chemical products including business planning, information systems, Chairman & Managing Director research & development, product development, and marketing › Holds a BA in Econom
Slide 22: Way Forward
Way Forward Shelf-Life Solutions Performance Chemicals Aroma Ingredients Health and Wellness • Aim to expand Diphenol chain, • Introduce specialized and customized • Maintaining market leadership for specifically focusing on expanding products within the vanillin range, catering Antioxidants • Impro
Slide 23: Historical Financial Highlights
Historical Financial Highlights 22
Slide 24: Operational Revenue Break-Up
Operational Revenue Break-Up Shelf-Life Extension (Rs. In Mn) Blends (Rs. In Mn) Total Shelf-Life Solution (Rs. In Mn) 4,576 5,103 9,679 3,812 4,168 7,980 2,860 3,135 3,311 6,171 2,381 5,516 2,248 2,608 4,856 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 Performance Chem
Slide 25: Regional Highlights
Regional Highlights CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) 7,894 3,533 4,883 6,855 3,198 4,395 5,798 6,000 2,571 2,735 3,762 5,481 3,296 2,172 3,091 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 CFS Brazil (Rs. In Mn) CFS Wanglong (Rs. In Mn)
Slide 26: Historical Financial Highlights
Historical Financial Highlights Margin Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn) 7.7% 12.5% 15.3% 10.8% 12.7% 0.3% 2.8% 5.5% 4.3% 2.4% 16,816 2,131 654 604 14,121 1,819 11,871 1,528 10,491 1,307 398 8,922 298 687 30 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 F
Slide 27: Thank You!
Thank You! Camlin Fine Sciences Ltd. CIN – L74100MH1993PLCO75361 Mr. Santosh Parab- CFO Email – santosh.parab@camlinfs.com www.camlinfs.com Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Mr. Shrikant Sangani / Ms. Shaily Patwa Email – shrikant.sangani@sgapl.net / shaily.p@sgapl.net